Tak Paul Peter
Insider CIK 1873905 · CADL Chief Executive Officer, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| CADL Candel Therapeutics, Inc. | S Sale | 2026-09-11 | 2026-09-11 | 59,379 | $10.46 | $621.1K | 113,321 | SEC↗ |
| CADL Candel Therapeutics, Inc. | S Sale | 2026-09-11 | 2026-09-11 | 59,379 | $10.46 | $620.9K | 113,321 | SEC↗ |
| CADL Candel Therapeutics, Inc. | M Exercise deriv | 2026-09-10 | 2026-09-11 | 125,000 | — | $0 | 1,638,968 | SEC↗ |
| CADL Candel Therapeutics, Inc. | S Sale | 2026-09-10 | 2026-09-11 | 220,866 | $11.50 | $2.54M | 172,700 | SEC↗ |
| CADL Candel Therapeutics, Inc. | M Exercise | 2026-09-10 | 2026-09-11 | 125,000 | $1.55 | $193.8K | 393,566 | SEC↗ |
| CADL Candel Therapeutics, Inc. | M Exercise deriv | 2026-09-10 | 2026-09-11 | 125,000 | — | $0 | 1,638,968 | SEC↗ |
| CADL Candel Therapeutics, Inc. | S Sale | 2026-09-10 | 2026-09-11 | 220,866 | $11.50 | $2.54M | 172,700 | SEC↗ |
| CADL Candel Therapeutics, Inc. | M Exercise | 2026-09-10 | 2026-09-11 | 125,000 | $1.55 | $193.8K | 393,566 | SEC↗ |
| CADL Candel Therapeutics, Inc. | A Award deriv | 2026-01-26 | 2026-01-28 | 629,000 | — | $0 | 629,000 | SEC↗ |
| CADL Candel Therapeutics, Inc. | A Award | 2025-06-25 | 2025-06-26 | 42,826 | $4.67 | $200.0K | 268,566 | SEC↗ |
| CADL Candel Therapeutics, Inc. | S Sale | 2025-03-19 | 2025-03-20 | 400 | $9.00 | $3.6K | 225,740 | SEC↗ |
| CADL Candel Therapeutics, Inc. | S Sale | 2025-03-18 | 2025-03-20 | 25,772 | $8.77 | $226.0K | 226,140 | SEC↗ |
| CADL Candel Therapeutics, Inc. | A Award deriv | 2025-02-12 | 2025-02-14 | 525,000 | — | $0 | 525,000 | SEC↗ |
| CADL Candel Therapeutics, Inc. | S Sale | 2025-01-15 | 2025-01-17 | 21,704 | $7.23 | $156.9K | 251,912 | SEC↗ |
| CADL Candel Therapeutics, Inc. | S Sale | 2025-01-08 | 2025-01-10 | 21,172 | $8.22 | $174.0K | 273,616 | SEC↗ |
| CADL Candel Therapeutics, Inc. | S Sale | 2024-11-29 | 2024-12-03 | 48,847 | $4.56 | $222.7K | 294,788 | SEC↗ |
| CADL Candel Therapeutics, Inc. | M Exercise deriv | 2024-11-21 | 2024-11-21 | 12,900 | — | $0 | 1,763,968 | SEC↗ |
| CADL Candel Therapeutics, Inc. | M Exercise | 2024-11-21 | 2024-11-21 | 12,900 | $1.55 | $20.0K | 343,635 | SEC↗ |
| CADL Candel Therapeutics, Inc. | S Sale | 2024-07-17 | 2024-07-19 | 22,528 | $6.47 | $145.8K | 330,735 | SEC↗ |
| CADL Candel Therapeutics, Inc. | S Sale | 2024-07-11 | 2024-07-15 | 20,293 | $5.97 | $121.1K | 353,263 | SEC↗ |
| CADL Candel Therapeutics, Inc. | F Tax w/h | 2023-11-28 | 2023-11-30 | 43,443 | $0.90 | $39.1K | 373,556 | SEC↗ |
| CADL Candel Therapeutics, Inc. | A Award | 2023-11-26 | 2023-11-28 | 180,108 | — | $0 | 416,999 | SEC↗ |
| CADL Candel Therapeutics, Inc. | A Award deriv | 2023-04-28 | 2023-05-02 | 180,000 | — | $0 | 180,000 | SEC↗ |
| CADL Candel Therapeutics, Inc. | P Buy | 2022-12-09 | 2022-12-12 | 12,935 | $1.92 | $24.8K | 40,985 | SEC↗ |
| CADL Candel Therapeutics, Inc. | P Buy | 2022-12-08 | 2022-12-12 | 3,050 | $1.70 | $5.2K | 28,050 | SEC↗ |
| CADL Candel Therapeutics, Inc. | A Award | 2022-11-28 | 2022-11-30 | 195,906 | — | $0 | 220,906 | SEC↗ |
| CADL Candel Therapeutics, Inc. | A Award deriv | 2022-02-28 | 2022-03-01 | 330,000 | — | $0 | 330,000 | SEC↗ |
| CADL Candel Therapeutics, Inc. | P Buy | 2021-07-29 | 2021-08-02 | 25,000 | $8.00 | $200.0K | 25,000 | SEC↗ |